2017-02-001 - Platform-02 - Bioadhesive platform to perform bioactive gastrointestinal cancer treatment
The proposal is based on a new intestinal dressing with drug delivery functions for the treatment of gastrointestinal cancers that can be administered through the endoscope channel and easily adaptable to the patient regardless of the stage of the disease. The invention consists of a platform for the local and sustained release of active agents, mainly anticancer, but also anti-inflammatory drugs, for the gastrointestinal tract, for example to prevent tumor recurrence after resection, or reducing inflammation in patients with inflammatory bowel disease or inflammatory colitis.